The Effect of a Case Management Intervention on Drug Treatment Entry Among Treatment-Seeking Injection Drug Users With and Without Comorbid Antisocial Personality Disorder - Journal of Urban Health
- ️Strathdee, Steffanie A.
- ️Fri Mar 02 2007
Abstract
We examined the effect of a case management intervention on drug treatment entry among injection drug users (IDUs) with and without comorbid antisocial personality disorder (ASPD). Injection drug users attending the Baltimore Needle Exchange Program who sought and were granted referrals to opioid agonist treatment were randomized to receive a strengths-based case management intervention or passive referral. Of 162 IDUs, 22.8% met the DSM-IV criteria for ASPD. Compared to those without ASPD, IDUs with comorbid ASPD who spent 25 or more minutes with their case manager prior to their treatment entry date were 3.51 times more likely to enter treatment than those receiving less than 5 min, adjusting for intervention status, race, and treatment site (95% confidence interval 1.04–11.89). Providing case management services to IDUs with comorbid ASPD may facilitate treatment entry and reduce the negative consequences of drug abuse.
Access this article
Subscribe and save
- Get 10 units per month
- Download Article/Chapter or eBook
- 1 Unit = 1 Article or 1 Chapter
- Cancel anytime
Buy Now
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Instant access to the full article PDF.
References
Brooner RK, Greenfield L, Schmidt CW, Bigelow GE. Antisocial personality disorder and HIV infection among intravenous drug abusers. Am J Psychiatry. 1993;150:53–58.
Booth RE, Corsi KF, Mikulich SK. Improving entry to methadone maintenance among out-of-treatment injection drug users. J Subst Abuse Treat. 2003;24:305–311.
Dinwiddie SH, Cottler L, Compton W, Abdallah AB. Psychopathology and HIV risk behaviors among injection drug users in and out of treatment. Drug Alcohol Depend. 1996;43:1–11.
Gill K, Nolimal D, Crowley TJ. Antisocial personality disorder, HIV risk behavior and retention in methadone maintenance therapy. Drug Alcohol Depend. 1992;30:247–252.
Bell J, Mattick R, Hay A, Chan J, Hall W. Methadone maintenance and drug-related crime. J Subst Abuse. 1997;9:15–25.
Goodwin RD, Hamilton SP. Lifetime comorbidity of antisocial personality disorder and anxiety disorders among adults in the community. Psychiatry Res. 2003;117:159–166.
Brooner R, King V, Kidorf M, Schmidt CW, Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry. 1997;54:71–80.
RachBeisel J, Scott J, Dixon L. Co-occurring severe mental illness and substance use disorders: a review of recent research. Psychiatr Serv. 1999;50:1427–1434.
Havens JR, Strathdee SA. Antisocial personality disorder and opioid treatment outcomes: a review. Addict Disord Treat. 2005;4:85–97.
Robins LN. The intimate connection between antisocial personality and substance abuse. Soc Psychiatry Psychiatr Epidemiol. 1998;33:393–399.
Strathdee SA, Ricketts EP, Huettner S, et al. Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: results from a community-based behavioral intervention trial. Drug Alcohol Depend. 2006;83:225–232.
Rapp RC, Siegal HA, Fisher JH. A strengths-based model of case management/advocacy: adapting a mental health model to practice work with persons who have substance abuse problems. NIDA Res Monogr. 1992;127:79–91.
First MB, Spitzer RL, Gibbon M, Williams JB. The Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II), Part I: description. J Personal Disord. 1995;9:92–104.
Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry. 1992;49:624–629.
Strain EC, Stitzer ML, Bigelow GE. Early treatment time course of depressive symptoms in opiate addicts. J Nerv Ment Dis. 1991;179:215–221.
Sorensen JL, Copeland AL. Drug abuse treatment as an HIV prevention strategy: a review. Drug Alcohol Depend. 2000;59:17–31.
Acknowledgements
The authors gratefully acknowledge support from the National Institute on Drug Abuse (grant nos. DA09225 and DA015604), Dr. David Vlahov, Dr. Peter Hartsock, staff of the Baltimore NEP and Baltimore Substance Abuse Systems, Inc. and associated drug treatment programs, and staff and participants of the TRI.
Author information
Authors and Affiliations
Center on Drug and Alcohol Research, University of Kentucky College of Medicine, Lexington, KY, USA
Jennifer R. Havens
School of Social Work, University of Maryland, Baltimore, MD, USA
Llewellyn J. Cornelius
Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
Erin P. Ricketts, Steven Huettner & Steffanie A. Strathdee
Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
Carl A. Latkin
Department of Population and Family Health Sciences, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
David Bishai
School of Social Administration, Temple University, Philadelphia, PA, USA
Jacqueline J. Lloyd
Division of International Health and Cross-cultural Medicine, Department of Family Health Sciences, University of California San Diego School of Medicine, San Diego, CA, USA
Steffanie A. Strathdee
Authors
- Jennifer R. Havens
You can also search for this author inPubMed Google Scholar
- Llewellyn J. Cornelius
You can also search for this author inPubMed Google Scholar
- Erin P. Ricketts
You can also search for this author inPubMed Google Scholar
- Carl A. Latkin
You can also search for this author inPubMed Google Scholar
- David Bishai
You can also search for this author inPubMed Google Scholar
- Jacqueline J. Lloyd
You can also search for this author inPubMed Google Scholar
- Steven Huettner
You can also search for this author inPubMed Google Scholar
- Steffanie A. Strathdee
You can also search for this author inPubMed Google Scholar
Corresponding author
Correspondence to Jennifer R. Havens.
Additional information
Havens is with the Center on Drug and Alcohol Research, University of Kentucky College of Medicine, Lexington, KY, USA; Cornelius is with the School of Social Work, University of Maryland, Baltimore, MD, USA; Ricketts, Huettner, and Strathdee are with the Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA; Latkin is with the Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA; Bishai is with the Department of Population and Family Health Sciences, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA; Lloyd is with the School of Social Administration, Temple University, Philadelphia, PA, USA; Strathdee is with the Division of International Health and Cross-cultural Medicine, Department of Family Health Sciences, University of California San Diego School of Medicine, San Diego, CA, USA.
Rights and permissions
About this article
Cite this article
Havens, J.R., Cornelius, L.J., Ricketts, E.P. et al. The Effect of a Case Management Intervention on Drug Treatment Entry Among Treatment-Seeking Injection Drug Users With and Without Comorbid Antisocial Personality Disorder. J Urban Health 84, 267–271 (2007). https://doi.org/10.1007/s11524-006-9144-4
Published: 02 March 2007
Issue Date: March 2007
DOI: https://doi.org/10.1007/s11524-006-9144-4